4//SEC Filing
Bisker-Leib Vered 4
Accession 0000899243-22-022558
CIK 0001797336other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:15 PM ET
Size
5.4 KB
Accession
0000899243-22-022558
Insider Transaction Report
Form 4
Bisker-Leib Vered
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-13+6,250→ 6,250 totalExercise: $1.63Exp: 2032-06-12→ Common Stock (6,250 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
Related Parties
1- filerCIK 0001814093
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:15 PM ET
- Size
- 5.4 KB